(lp0
S'Insider Trading Activity Vical Incorporated   VP Sold 4250 ... Market Exclusive - 6 hours ago On 8/31/2012 James R Singer, Major Shareholder, bought 310,000 with an average share price of $3.51 per share and the total transaction amounting to $1,088,100.00.'
p1
aS'Vical Incorporated  Announces Earnings Results, Misses Expectations By ... Chaffey Breeze - 15 hours ago Vical logo Vical Incorporated  released its quarterly earnings data on Thursday. The company reported  earnings per share for the quarter, missing the consensus estimate of  by $0.04.Is Vical Incorporated  Ready to Rumble? - Morgan Research'
p2
aS'Vical Incorporated: Vical Announces News Release and Conference Call Schedule ... The Wall Street Transcript - Mar 2, 2017 SAN DIEGO, March 02, 2017  -- Vical Incorporated  today announced that the company will report financial results for the three months ended December 31, 2016, before the opening of trading on Thursday, March 9, and&nbsp;...Vical Incorporated  Valuation According To Analysts - UK Market News'
p3
aS'Investor Watch: Looking at Shares of Vical Incorporated  SKV News - 15 hours ago Taking a look at shares of Vical Incorporated , the stock has a Value Composite Score of 63. Based on a scale from 0 to 100, a score near zero would indicate an undervalued company and a higher score would signal an expensive or&nbsp;...'
p4
aS'Zacks: Analysts Set $8.00 Target Price for Vical Incorporated  BNB Daily  - Mar 24, 2017 Vical logo Vical Incorporated  has been assigned a consensus broker rating score of 0.00  from the one analysts that provide coverage for the stock, Zacks Investment Research reports.Latest Stocks: Zacks: Analysts Set $8.00 Target Price for Vical Incorporated ... - Petro Global News 24Vical Incorporated  Stock ABR At 1 - Markets Daily'
p5
aS'Stock Returns: Threshold Pharmaceuticals Inc  is Beating Vical ... CML News - Jan 31, 2017 This is a snapshot to compare the stock returns for Threshold Pharmaceuticals Inc  versus Vical Incorporated  .'
p6
aS'Vical and Astellas Announce Topline Results from a Phase 2 Study of ... GlobeNewswire  - Sep 19, 2016 SAN DIEGO and TOKYO, Sept. 19, 2016  -- Vical Incorporated  and Astellas Pharma Inc.  today announced topline results from a randomized, double-blind, placebo-controlled Phase 2 study evaluating the&nbsp;...Astellas, Vical herpes vaccine fails mid-stage study - ReutersVical, Astellas report miss in kidney transplant study with cytomegalovirus ... - BioWorld Online'
p7
aS'The Zacks: Brokerages Set $8.00 Price Target for Vical Incorporated  Petro Global News 24 - Mar 24, 2017 Shares of Vical Incorporated  have been given an average broker rating score of 0.00  from the one analysts that provide coverage for the company, Zacks Investment Research reports.'
p8
aS'Vical Reports Fourth Quarter 2016 Financial Results GlobeNewswire  - Mar 9, 2017 SAN DIEGO, March 09, 2017  -- Vical Incorporated  today reported financial results for the three and twelve months ended December 31, 2016.How Often Does Vical Incorporated  Beat Earnings Estimates? - Post AnalystVical Incorporated  to Release Earnings on Thursday - Chaffey Breeze'
p9
aS"Vical's Herpes Vaccine: An Update Seeking Alpha - Sep 12, 2013 With the failure of its Allovectin immunotherapy for multiple melanoma and the refocus of the company's resources on vaccines, Vical  finally provided some long-awaited information on the forthcoming Phase 1/2 trial of the company's herpes&nbsp;..."
p10
a.